RS51091B - 2-(amino-supstituisani)-4-aril piramidini i srodna jedinjenja korisna za lečenje inflamatornih bolesti - Google Patents
2-(amino-supstituisani)-4-aril piramidini i srodna jedinjenja korisna za lečenje inflamatornih bolestiInfo
- Publication number
- RS51091B RS51091B RSP-2009/0466A RSP20090466A RS51091B RS 51091 B RS51091 B RS 51091B RS P20090466 A RSP20090466 A RS P20090466A RS 51091 B RS51091 B RS 51091B
- Authority
- RS
- Serbia
- Prior art keywords
- aliphatic
- independently
- nitrogen atom
- orb
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53489804P | 2004-01-08 | 2004-01-08 | |
| PCT/US2005/000663 WO2005066139A2 (en) | 2004-01-08 | 2005-01-10 | 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51091B true RS51091B (sr) | 2010-10-31 |
Family
ID=34749013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP-2009/0466A RS51091B (sr) | 2004-01-08 | 2005-01-10 | 2-(amino-supstituisani)-4-aril piramidini i srodna jedinjenja korisna za lečenje inflamatornih bolesti |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7732444B2 (sr) |
| EP (2) | EP1701944B1 (sr) |
| JP (1) | JP2007517895A (sr) |
| AR (1) | AR047185A1 (sr) |
| AT (1) | ATE437861T1 (sr) |
| AU (1) | AU2005204060A1 (sr) |
| CA (1) | CA2559888A1 (sr) |
| CY (1) | CY1109529T1 (sr) |
| DE (1) | DE602005015677D1 (sr) |
| DK (1) | DK1701944T3 (sr) |
| ES (1) | ES2330863T3 (sr) |
| HR (1) | HRP20090572T1 (sr) |
| PL (1) | PL1701944T3 (sr) |
| PT (1) | PT1701944E (sr) |
| RS (1) | RS51091B (sr) |
| SI (1) | SI1701944T1 (sr) |
| TW (1) | TW200533357A (sr) |
| WO (1) | WO2005066139A2 (sr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200533357A (en) * | 2004-01-08 | 2005-10-16 | Millennium Pharm Inc | 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| BRPI0508230A (pt) * | 2004-03-30 | 2007-07-17 | Chiron Corp | derivados de tiofeno substituìdo como agentes anti-cáncer |
| GB0428250D0 (en) * | 2004-12-23 | 2005-01-26 | Novartis Ag | Organic compounds |
| WO2007076247A1 (en) * | 2005-12-21 | 2007-07-05 | Boehringer Ingelheim International Gmbh | Pyrimidine derivatives useful as inhibitors of pkc-theta |
| JP5385125B2 (ja) * | 2006-03-22 | 2014-01-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ＭＤＭ２とｐ５３の間の相互作用の阻害剤 |
| EP2529623A3 (en) | 2007-04-03 | 2013-03-13 | E. I. du Pont de Nemours and Company | Substituted benzene fungicides |
| PT2215117E (pt) * | 2007-10-30 | 2015-04-01 | Genentech Inc | Purificação de anticorpo por cromatografia de troca de catiões |
| EP2253618A1 (en) | 2008-02-27 | 2010-11-24 | Takeda Pharmaceutical Company Limited | Compound having 6-membered aromatic ring |
| EP2169665B1 (en) | 2008-09-25 | 2018-05-02 | LG Electronics Inc. | A method and an apparatus for processing a signal |
| WO2011083481A2 (en) * | 2010-01-11 | 2011-07-14 | Healor Ltd. | Method for treatment of inflammatory disease and disorder |
| AU2011274369A1 (en) * | 2010-07-02 | 2012-12-06 | Ventana Medical Systems, Inc. | Hapten conjugates for target detection |
| ES2543050T3 (es) | 2011-02-28 | 2015-08-14 | Array Biopharma, Inc. | Inhibidores de serina/treonina quinasa |
| US9187462B2 (en) | 2011-08-04 | 2015-11-17 | Array Biopharma Inc. | Substituted quinazolines as serine/threonine kinase inhibitors |
| SI2820009T1 (en) | 2012-03-01 | 2018-05-31 | Array Biopharma, Inc. | Serine / Threonine kinase inhibitors |
| RU2638540C1 (ru) | 2012-04-24 | 2017-12-14 | Вертекс Фармасьютикалз Инкорпорейтед | Ингибиторы днк-пк |
| BR112015004548A2 (pt) | 2012-08-27 | 2017-08-08 | Array Biopharma Inc | inibidores de serina/treonina para tratamento de doenças hiperproliferativas |
| HRP20211855T1 (hr) | 2013-03-12 | 2022-03-04 | Vertex Pharmaceuticals Incorporated | Inhibitori dnk-pk |
| AU2014324092B2 (en) | 2013-09-18 | 2020-02-06 | Epiaxis Therapeutics Pty Ltd | Stem cell modulation II |
| PL3424920T3 (pl) | 2013-10-17 | 2020-11-16 | Vertex Pharmaceuticals Incorporated | Kokryształy (S)-N-metylo-8-(1-((2'-metylo-4’,6'-dideutero-[4,5'-bipirymidyn]-6-ylo)amino)propan-2-ylo)chinolino-4-karboksyamidu i ich deuterowane pochodne jako inhibitory DNA-PK |
| CA2958704A1 (en) | 2014-08-25 | 2016-03-03 | University Of Canberra | Compositions for modulating cancer stem cells and uses therefor |
| KR20190062485A (ko) | 2016-09-27 | 2019-06-05 | 버텍스 파마슈티칼스 인코포레이티드 | Dna-손상제 및 dna-pk 저해제의 조합을 사용한 암 치료 방법 |
| WO2023104744A1 (en) | 2021-12-06 | 2023-06-15 | Helmholtz-Zentrum Dresden-Rossendorf E.V. | 3-((3-([1,1'-biphenyl]-3-ylmethoxy)phenoxy)methyl)benzonitrile derivatives and the use thereof |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698697A (en) | 1995-07-19 | 1997-12-16 | Mitsubishi Chemical Corporation | 2-cyanopiperazine and method of producing the same |
| WO1999032121A1 (en) * | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| ATE245641T1 (de) * | 1998-02-17 | 2003-08-15 | Tularik Inc | Antivirale pyrimidinderivate |
| JP4533534B2 (ja) | 1998-06-19 | 2010-09-01 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | グリコーゲンシンターゼキナーゼ３のインヒビター |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| IL143906A0 (en) | 1998-12-24 | 2002-04-21 | Aventis Pharmaceuticals Produs | Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xa inhibitors |
| US6492516B1 (en) * | 1999-05-14 | 2002-12-10 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
| CA2376951A1 (en) | 1999-06-30 | 2001-01-04 | Peter J. Sinclair | Src kinase inhibitor compounds |
| PL366110A1 (en) * | 1999-08-13 | 2005-01-24 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| GB0003224D0 (en) * | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
| US6869956B2 (en) | 2000-10-03 | 2005-03-22 | Bristol-Myers Squibb Company | Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK) |
| IL155089A0 (en) | 2000-10-12 | 2003-10-31 | Merck & Co Inc | Aza and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| JP4160401B2 (ja) * | 2001-03-29 | 2008-10-01 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｃ−ｊｕｎｎ末端キナーゼ（ｊｎｋ）および他のタンパク質キナーゼのインヒビター |
| WO2002083667A2 (en) * | 2001-04-13 | 2002-10-24 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| GB0112803D0 (en) | 2001-05-25 | 2001-07-18 | Glaxo Group Ltd | Pyrimidine derivatives |
| JP2005511608A (ja) | 2001-11-07 | 2005-04-28 | エフ．ホフマン−ラ ロシュ アーゲー | アミノピリミジン類及び−ピリジン類 |
| TWI319387B (en) * | 2002-04-05 | 2010-01-11 | Astrazeneca Ab | Benzamide derivatives |
| EP1515964A1 (en) * | 2002-06-14 | 2005-03-23 | ALTANA Pharma AG | Substituted diaminopyrimidines |
| TW200510311A (en) | 2002-12-23 | 2005-03-16 | Millennium Pharm Inc | CCr8 inhibitors |
| WO2004067516A1 (en) | 2003-01-30 | 2004-08-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| AU2004229392A1 (en) | 2003-04-09 | 2004-10-28 | Exelixis, Inc. | Tie-2 modulators and methods of use |
| TW200519106A (en) * | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
| US7459460B2 (en) | 2003-05-28 | 2008-12-02 | Bristol-Myers Squibb Company | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| TW200533357A (en) * | 2004-01-08 | 2005-10-16 | Millennium Pharm Inc | 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| RU2006135112A (ru) * | 2004-03-05 | 2008-04-10 | Чирон Корпорейшн (Us) | Тест-система in vitro для прогнозирования устойчивости пациента к терапевтическим средствам |
| BRPI0508230A (pt) * | 2004-03-30 | 2007-07-17 | Chiron Corp | derivados de tiofeno substituìdo como agentes anti-cáncer |
| JP5097539B2 (ja) | 2004-05-07 | 2012-12-12 | アムジエン・インコーポレーテツド | タンパク質キナーゼ調節剤および使用方法 |
| MY144044A (en) | 2004-06-10 | 2011-07-29 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| WO2006050476A2 (en) * | 2004-11-03 | 2006-05-11 | Vertex Pharmaceuticals Incorporated | Pyrimidine derivatives as ion channel modulators and methods of use |
| TWI359810B (en) | 2004-11-04 | 2012-03-11 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivative containing thiazole rin |
| CN101115749B (zh) | 2004-12-17 | 2011-06-22 | 安姆根有限公司 | 氨基嘧啶化合物和使用方法 |
| US20060178388A1 (en) | 2005-02-04 | 2006-08-10 | Wrobleski Stephen T | Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| DE102005034821A1 (de) * | 2005-07-26 | 2007-02-08 | Fleissner Gmbh | Voluminöse Faserlaminate und ihre Herstellung |
| TWM293131U (en) * | 2006-01-10 | 2006-07-01 | Shuen Tai Prec Entpr Co Ltd | Handheld power hammer |
-
2005
- 2005-01-07 TW TW094100533A patent/TW200533357A/zh unknown
- 2005-01-10 SI SI200530816T patent/SI1701944T1/sl unknown
- 2005-01-10 US US11/032,299 patent/US7732444B2/en not_active Expired - Fee Related
- 2005-01-10 RS RSP-2009/0466A patent/RS51091B/sr unknown
- 2005-01-10 AR ARP050100080A patent/AR047185A1/es unknown
- 2005-01-10 CA CA002559888A patent/CA2559888A1/en not_active Abandoned
- 2005-01-10 AT AT05726205T patent/ATE437861T1/de active
- 2005-01-10 ES ES05726205T patent/ES2330863T3/es active Active
- 2005-01-10 EP EP05726205A patent/EP1701944B1/en active Active
- 2005-01-10 PT PT05726205T patent/PT1701944E/pt unknown
- 2005-01-10 WO PCT/US2005/000663 patent/WO2005066139A2/en active Application Filing
- 2005-01-10 DK DK05726205T patent/DK1701944T3/da active
- 2005-01-10 AU AU2005204060A patent/AU2005204060A1/en not_active Abandoned
- 2005-01-10 DE DE602005015677T patent/DE602005015677D1/de active Active
- 2005-01-10 JP JP2006549475A patent/JP2007517895A/ja active Pending
- 2005-01-10 EP EP09009692A patent/EP2123647A1/en not_active Withdrawn
- 2005-01-10 PL PL05726205T patent/PL1701944T3/pl unknown
-
2009
- 2009-10-27 CY CY20091101118T patent/CY1109529T1/el unknown
- 2009-10-28 HR HR20090572T patent/HRP20090572T1/hr unknown
-
2010
- 2010-04-26 US US12/767,139 patent/US8268822B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1701944T3 (da) | 2009-11-09 |
| US20110071134A1 (en) | 2011-03-24 |
| EP1701944A2 (en) | 2006-09-20 |
| AU2005204060A1 (en) | 2005-07-21 |
| WO2005066139A3 (en) | 2005-10-13 |
| DE602005015677D1 (de) | 2009-09-10 |
| EP2123647A1 (en) | 2009-11-25 |
| HRP20090572T1 (hr) | 2010-01-31 |
| PT1701944E (pt) | 2009-11-03 |
| US7732444B2 (en) | 2010-06-08 |
| TW200533357A (en) | 2005-10-16 |
| PL1701944T3 (pl) | 2010-01-29 |
| ES2330863T3 (es) | 2009-12-16 |
| CY1109529T1 (el) | 2014-08-13 |
| EP1701944B1 (en) | 2009-07-29 |
| SI1701944T1 (sl) | 2010-03-31 |
| ATE437861T1 (de) | 2009-08-15 |
| AR047185A1 (es) | 2006-01-11 |
| US8268822B2 (en) | 2012-09-18 |
| US20060040968A1 (en) | 2006-02-23 |
| CA2559888A1 (en) | 2005-07-21 |
| JP2007517895A (ja) | 2007-07-05 |
| WO2005066139A2 (en) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS51091B (sr) | 2-(amino-supstituisani)-4-aril piramidini i srodna jedinjenja korisna za lečenje inflamatornih bolesti | |
| HRP20180335T1 (hr) | Kondenzirani derivati imidazola korisni kao ido inhibitori | |
| RS52295B (sr) | Spiro-oksindolna jedinjenja i njihova upotreba u vidu terapeutskih sredstava | |
| HRP20180916T1 (hr) | Inhibitori demetilaze od lsd1 na bazi arilciklopropilamina i njihova medicinska uporaba | |
| HRP20200648T1 (hr) | Derivati sulfamoilpirolamida i njihova uporaba kao lijekova za liječenje hepatitisa b | |
| HRP20210879T1 (hr) | Inhibitori beta-laktamaze | |
| IL272115B (en) | An aryl-phosphorus-oxygen compound as an egfr kinase inhibitor | |
| HRP20210775T1 (hr) | Predlijekovi fenolnih agonista trpv1 | |
| HRP20211041T1 (hr) | Anthelmintski depsipeptidni spojevi | |
| RS54718B1 (sr) | Derivati 1,2,4-tiazolidin-3-ona i njihova upotreba u lečenju kancera | |
| HRP20221112T1 (hr) | Derivati benzodiazepina kao inhibitori rsv | |
| JP2011507893A5 (sr) | ||
| HRP20160415T1 (hr) | Inhibitori beta-sekretaze | |
| RU2019106484A (ru) | Гетероциклическое соединение | |
| HRP20090442T1 (hr) | Heteroaril-tetrahidropiridil spojevi korisni za liječenje ili prevenciju boli | |
| HRP20120993T1 (hr) | Anacetrapib i drugi inhibitori cetp | |
| HRP20100032T1 (hr) | Tiadiazolidinoni kao inhibitori gsk-3 | |
| HRP20211979T1 (hr) | Postupak za pripravu enantiomerno obogaćenih spojeva izoksazolina – kristalnog toluen solvata (s)-afoksolanera | |
| HRP20030436B1 (en) | Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds | |
| RS53836B1 (sr) | 2-anilinbenzimidazol-6-karboksamidi kao anti-inflamatorni agensi | |
| JP2015509534A5 (sr) | ||
| HRP20140011T1 (hr) | Derivati oksazina i njihova uporaba u lijeäśenju neuroloških poremeä†aja | |
| WO2008096870A1 (ja) | アザ架橋環化合物 | |
| RS52126B (sr) | Derivati azabifenilaminobenzoične kiseline kao inhibitori dehidrogenaze dihidroorotata (dhodh) | |
| HRP20230737T1 (hr) | 4-metilsulfonil-supstituirani spojevi piperidin uree korisni za liječenje srčanih poremećaja kao što je dilatirana kardiomiopatija (dcm) |